- In April 2023, CAE Healthcare, a global leader in medical simulation, announced the launch of CAE VimedixAR, an augmented reality ultrasound simulator developed in partnership with Microsoft HoloLens. This advancement enhances training by offering a 360-degree anatomical view, helping learners visualize complex procedures in real-time. With CAE holding approximately 19.2% of the global surgical simulator market share in 2024, this innovation underscores the company's ongoing commitment to immersive simulation technologies in clinical education
- In March 2023, Surgical Science Sweden AB, which captured 13.6% of the global market share in 2024, acquired SenseGraphics AB, a provider of advanced VR-based medical simulation software. This acquisition aimed to strengthen Surgical Science’s presence in high-fidelity simulation, combining cutting-edge graphics with advanced haptics. The strategic move supports the company’s expansion into more advanced and interactive simulation platforms, driving the broader adoption of VR-based simulators in laparoscopic and robotic surgery training
- In March 2023, Mentice AB, which accounted for around 8.9% of the global market in 2024, launched Mentice VIST One TEE, a new simulator dedicated to transesophageal echocardiography (TEE) training. This system allows interventional teams to practice complex cardiac procedures using real-time image feedback. The launch aligns with the growing demand for cardiology-focused simulation training in hospitals and academic centers
- In February 2023, 3D Systems Corporation, representing 7.4% of global revenue share in the surgical simulation space, announced the expansion of its Simbionix portfolio to include robot-assisted surgical training modules. These new training systems are tailored for the Da Vinci surgical platform, addressing the rising demand for robotic surgery education. This development positions 3D Systems as a key contributor to the advancement of robotic surgery simulation technologies
- In January 2023, VirtaMed AG, holding 5.7% of the market share, unveiled a strategic collaboration with major urology training programs in Europe to integrate its UroSim simulator into residency curricula. This partnership supports enhanced proficiency in urological procedures and reflects the increasing institutional adoption of surgical simulators as mandatory training tools
